Literature DB >> 26912006

Prediction of esophageal varices and variceal hemorrhage in patients with acute upper gastrointestinal bleeding.

Don C Rockey1, Alan Elliott2, Thomas Lyles3.   

Abstract

In patients with upper gastrointestinal bleeding (UGIB), identifying those with esophageal variceal hemorrhage prior to endoscopy would be clinically useful. This retrospective study of a large cohort of patients with UGIB used logistic regression analyses to evaluate the platelet count, aspartate aminotransferase (AST) to platelet ratio index (APRI), AST to alanine aminotransferase (ALT) ratio (AAR) and Lok index (all non-invasive blood markers) as predictors of variceal bleeding in (1) all patients with UGIB and (2) patients with cirrhosis and UGIB. 2233 patients admitted for UGIB were identified; 1034 patients had cirrhosis (46%) and of these, 555 patients (54%) had acute UGIB due to esophageal varices. In all patients with UGIB, the platelet count (cut-off 122,000/mm(3)), APRI (cut-off 5.1), AAR (cut-off 2.8) and Lok index (cut-off 0.9) had area under the curve (AUC)s of 0.80 0.82, 0.64, and 0.80, respectively, for predicting the presence of varices prior to endoscopy. To predict varices as the culprit of bleeding, the platelet count (cut-off 69,000), APRI (cut-off 2.6), AAR (cut-off 2.5) and Lok Index (0.90) had AUCs of 0.76, 0.77, 0.57 and 0.73, respectively. Finally, in patients with cirrhosis and UGIB, logistic regression was unable to identify optimal cut-off values useful for predicting varices as the culprit bleeding lesion for any of the non-invasive markers studied. For all patients with UGIB, non-invasive markers appear to differentiate patients with varices from those without varices and to identify those with a variceal culprit lesion. However, these markers could not distinguish between a variceal culprit and other lesions in patients with cirrhosis.
Copyright © 2016 American Federation for Medical Research.

Entities:  

Keywords:  Endoscopy; Hypertension, Portal; Liver Cirrhosis

Mesh:

Substances:

Year:  2016        PMID: 26912006     DOI: 10.1136/jim-2015-000047

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  13 in total

1.  Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?

Authors:  Kumar Sandrasegaran; Enming Cui; Reem Elkady; Pauley Gasparis; Gitasree Borthakur; Mark Tann; Suthat Liangpunsakul
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

Review 2.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 3.  Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.

Authors:  Gyorgy Baffy
Journal:  Dig Dis Sci       Date:  2018-01-22       Impact factor: 3.199

4.  Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India.

Authors:  Harit Goverdhan Kothari; Sudhir Jagdishoprasad Gupta; Nitin Rangrao Gaikwad; Tushar Hiralal Sankalecha; Amol Rajendra Samarth
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

Review 5.  Invasive and non-invasive assessment of portal hypertension.

Authors:  Jonathan Chung-Fai Leung; Thomson Chi-Wang Loong; James Pang; Jeremy Lok Wei; Vincent Wai-Sun Wong
Journal:  Hepatol Int       Date:  2017-03-30       Impact factor: 6.047

6.  Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis.

Authors:  Mohamed Yousri Taher; Abeer El-Hadidi; Assem El-Shendidi; Ahmed Sedky
Journal:  GE Port J Gastroenterol       Date:  2021-07-27

Review 7.  Value of Liver Function Tests in Cirrhosis.

Authors:  Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2021-11-14

Review 8.  Statins for treatment of chronic liver disease.

Authors:  Mohamad Kareem Marrache; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2021-05-01       Impact factor: 3.287

9.  Non-invasive diagnosis of variceal bleeding: choose the right target population and identify the right culprit.

Authors:  Paul Calès; Alice Nanelin Guingané; Frédéric Oberti; Roger Arsène Sombié
Journal:  Ann Transl Med       Date:  2020-06

10.  External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study.

Authors:  Qianqian Li; Yunhai Wu; Qiang Zhu; Fanping Meng; Su Lin; Bang Liu; Bimin Li; Shanhong Tang; Yida Yang; Yiling Li; Shanshan Yuan; Yu Chen; Xingshun Qi
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.